Performance of PREMM5, clinical criteria, and immunohistochemistry for MMR proteins in genetic risk assessment of Mexican patients with colorectal cancer

PLOS One · Published 2026-08-04 · DOI 10.1371/journal.pone.0354795

Free full text

Authors (16)

José Luis Rodríguez-Olivares, Dione Aguilar-y-Méndez, Tamara N. Kimball, Pamela Rivero-García, Javier Rios-Valencia, Sandra Santuario-Facio, Augusto Rojas-Martinez, Rocío Ortiz-López, Angélica Leticia Barraza-Arellano, Alejandro Aranda-Gutierrez, Jazmín Arteaga-Vazquez, Héctor De-La-Mora-Molina, Josef Herzog, Joanne M. Jeter, Jeffrey N. Weitzel, Yanin Chávarri-Guerra

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Rodríguez-Olivares, J., Aguilar-y-Méndez, D., Kimball, T., et al. (2026). Performance of PREMM5, clinical criteria, and immunohistochemistry for MMR proteins in genetic risk assessment of Mexican patients with colorectal cancer. PLOS One. https://doi.org/10.1371/journal.pone.0354795

Related articles